Mandatory notification regarding exercise and trade of subscription rights and trade of shares NewsRonny SkuggedalDecember 21, 2016
Update on the existing pre-clinical research collaboration agreement with a top-10 large pharma company NewsRonny SkuggedalDecember 13, 2016
PCI Biotech and eTheRNA immunotherapies initiate research collaboration NewsRonny SkuggedalDecember 8, 2016
Notice to the extraordinary general meeting to resolve a fully underwritten Rights Issue of NOK 70 million NewsRonny SkuggedalNovember 17, 2016
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 70 million NewsRonny SkuggedalNovember 17, 2016
PCI Biotech to present poster at the ESMO Symposium on Immuno-Oncology 2016 NewsRonny SkuggedalNovember 4, 2016
Results from the bile duct cancer study will be presented as late-breaking news at United European Gastroenterology Week NewsRonny SkuggedalOctober 17, 2016
PCI Biotech to present poster at the Second International Cancer Immunotherapy Conference NewsRonny SkuggedalSeptember 23, 2016
PCI Biotech to present phase I results at Nordic Life Science Days 2016 NewsRonny SkuggedalSeptember 13, 2016
Independent evaluation confirms early promising signs of efficacy in the phase I/II bile duct cancer study NewsRonny SkuggedalSeptember 6, 2016
PCI Biotech and BioNTech initiates preclinical research collaboration NewsRonny SkuggedalSeptember 1, 2016
